Toledo M S, Levery S B, Suzuki E, Straus A H, Takahashi H K
Department of Biochemistry, Universidade Federal de São Paulo/Escola Paulista de Medicina, Rua Botucatu 862, 04023-900, São Paulo, SP, Brasil.
Glycobiology. 2001 Feb;11(2):113-24. doi: 10.1093/glycob/11.2.113.
Cerebroside (monohexosylceramide) components were identified in neutral lipids extracted from both the yeast and mycelial forms of the thermally dimorphic mycopathogen Histoplasma capsulatum. The components were purified from both forms and their structures elucidated by 1- and 2-dimensional nuclear magnetic resonance (NMR) spectroscopy, electrospray ionization mass spectrometry (ESI-MS), and low energy tandem collision-induced dissociation mass spectrometry (ESI-MS/CID-MS). Both components were characterized as beta-glucopyranosylceramides (GlcCers) containing (4E,8E)-9-methyl-4,8-sphingadienine as the long-chain base, attached to 18-carbon 2-hydroxy fatty N-acyl components. However, while the fatty acid of the yeast form GlcCer was virtually all N-2'-hydroxyoctadecanoate, the mycelium form GlcCer was characterized by almost exclusive expression of N-2'-hydroxy-(E)-delta(3)-octadecenoate. These results suggest that the yeast-mycelium transition is accompanied by up-regulation of an as yet uncharacterized ceramide or cerebroside 2-hydroxy fatty N-acyl (E)-delta(3)-desaturase activity. They also constitute further evidence for the existence of two distinct pathways for ceramide biosynthesis in fungi, since glycosylinositol phosphorylceramides (GIPCs), the other major class of fungal glycosphingolipids, are found with ceramides consisting of 4-hydroxysphinganine (phytosphingosine) and longer chain 2-hydroxy fatty acids. In addition to identification of the major glucocerebroside components, minor components (< 5%) detectable by molecular weight differences in the ESI-MS profiles were also characterized by tandem ESI-MS/CID-MS analysis. These minor components were identified as variants differing in fatty acyl chain length, or the absence of the sphingoid 9-methyl group or (E)-delta(8)-unsaturation, and are hypothesized to be either biosynthetic intermediates or the result of imperfect chemical transformation by the enzymes responsible for these features. Possible implications of these findings with respect to chemotaxonomy, compartmentalization of fungal glycosphingolipid biosynthetic pathways, and regulation of morphological transitions in H.capsulatum and other dimorphic fungi are discussed.
在从热双态致病性真菌荚膜组织胞浆菌的酵母型和菌丝型中提取的中性脂质中,鉴定出了脑苷脂(单己糖神经酰胺)成分。从这两种形态中纯化出这些成分,并通过一维和二维核磁共振(NMR)光谱、电喷雾电离质谱(ESI-MS)以及低能串联碰撞诱导解离质谱(ESI-MS/CID-MS)阐明了它们的结构。两种成分均被鉴定为β-吡喃葡萄糖基神经酰胺(GlcCers),其含有(4E,8E)-9-甲基-4,8-鞘氨二烯作为长链碱基,连接到18碳的2-羟基脂肪酸N-酰基成分上。然而,酵母型GlcCer的脂肪酸几乎全是N-2'-羟基十八烷酸,而菌丝型GlcCer的特征是几乎只表达N-2'-羟基-(E)-δ(3)-十八碳烯酸。这些结果表明,酵母-菌丝体转变伴随着一种尚未鉴定的神经酰胺或脑苷脂2-羟基脂肪酸N-酰基(E)-δ(3)-去饱和酶活性的上调。它们还进一步证明了真菌中存在两种不同的神经酰胺生物合成途径,因为另一类主要的真菌糖鞘脂糖基肌醇磷酸神经酰胺(GIPCs)与由4-羟基鞘氨醇(植物鞘氨醇)和更长链的2-羟基脂肪酸组成的神经酰胺一起被发现。除了鉴定主要的葡萄糖脑苷脂成分外,通过ESI-MS谱图中的分子量差异可检测到的次要成分(<5%)也通过串联ESI-MS/CID-MS分析进行了表征。这些次要成分被鉴定为脂肪酸酰基链长度不同、鞘氨醇9-甲基缺失或(E)-δ(8)-不饱和缺失的变体,并被推测为生物合成中间体或负责这些特征的酶进行不完全化学转化的结果。讨论了这些发现对于化学分类学、真菌糖鞘脂生物合成途径的区室化以及荚膜组织胞浆菌和其他双态真菌形态转变调控的可能影响。